@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZGWQ380R-R mesh:pharmacologicalAction jvr:-WC6FH6FQ-K .
jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VZXKBM75-9
  skos:prefLabel "Central Nervous System Agents"@en, "Agents du système nerveux central"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-WC6FH6FQ-K .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-H53M5J46-7 mesh:pharmacologicalAction jvr:-WC6FH6FQ-K .
jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-K32P5ZN6-N mesh:pharmacologicalAction jvr:-WC6FH6FQ-K .
jvr:-WC6FH6FQ-K
  mesh:allowableQualifier jvr:-NFTHND7Q-8, jvr:-SBNWSM1T-R, jvr:-S0CS1X5R-5, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-NKM836P1-M, jvr:-WK5F724J-1, jvr:-G30ZJ446-J, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-H7K65Q8S-Z, jvr:-BT300B3G-Q, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-W6SQV79N-S, jvr:-TJHVZCRZ-0 ;
  dc:modified "2014-06-25"^^xsd:date ;
  dc:established "1995-01-01"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  dc:created "1994-06-03"^^xsd:date ;
  skos:broader jvr:-VZXKBM75-9 ;
  skos:inScheme jvr: ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D018726> ;
  skos:definition "Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias."@en ;
  skos:altLabel "Movement Disorder Agents"@en, "Médicaments antidyskinésiques"@fr, "Agents antidyskinésiques"@fr, "Agents anti-dyskinésie"@fr ;
  skos:narrower jvr:-M4W33FZ9-8 ;
  skos:prefLabel "Antidyskinésiques"@fr, "Anti-Dyskinesia Agents"@en .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-VJ0X0F6B-B mesh:pharmacologicalAction jvr:-WC6FH6FQ-K .
jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M4W33FZ9-8
  skos:prefLabel "Antiparkinson Agents"@en, "Antiparkinsoniens"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-WC6FH6FQ-K .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .